CSIMarket Company Name, Ticker, Competitors, else..
 
Akoya Biosciences Inc   (NASDAQ: AKYA)
 
Price: $1.2900 $-0.07 -5.147%
Day's High: $1.64 Week Perf: -0.77 %
Day's Low: $ 1.29 30 Day Perf: 3.2 %
Volume (M): 715,200 52 Wk High: $ 0.00
Volume (M$): $ 923 52 Wk Avg: $0.00
Open: $1.41 52 Wk Low: $0.00



 Market Capitalization (Millions $) 64
 Shares Outstanding (Millions) 50
 Employees 333
 Revenues (TTM) (Millions $) 79
 Net Income (TTM) (Millions $) -48
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 2

Business Description


Akoya Biosciences Inc is a company focused on developing and commercializing innovative imaging platforms and reagents for high-content, biomarker analysis in tissue samples. Their technologies enable researchers and clinicians to gain deeper insights and understanding of cellular interactions, tissue structure, and spatial distribution of biomarkers in biological samples. Akoya's flagship product, the CODEX system, combines multiplexed imaging with computational analysis to provide high-resolution spatial information in tissue samples. Their solutions are used in various fields including oncology, neuroscience, immunology, and infectious diseases. Akoya Biosciences Inc aims to accelerate drug discovery, biomarker identification, and refine diagnostics by providing researchers with advanced imaging tools.


   Company Address: 100 Campus Drive Marlborough 1752 MA
   Company Phone Number: 896-8401   Stock Exchange / Ticker: NASDAQ AKYA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A   -3.13%    
AVTR   -1.53%    
BRKR   -1.44%    
ILMN   -7.94%    
MTD   -1.87%    
RVTY        1.4% 
• View Complete Report
   



Management Announcement

Navigating Innovation and Adversity: Akoya Biosciences’ Journey in Spatial Proteomics,

Published Mon, Dec 9 2024 1:00 PM UTC

Spatial Proteomics: A Double-Edged Sword for Akoya Biosciences The Rise of Spatial Proteomics2024 has marked a significant milestone in the field of biological research as Nature Methods designated spatial proteomics as its Method of the Year. This recognition underscores the transformative capabilities of spatial proteomics in understanding biological systems, paving the...
Product Service News

Transforming Immuno-Oncology Akoya Biosciences Innovative Leap with the PhenoCode Discovery IO60 Amidst Market Chall...

Published Tue, Nov 5 2024 1:00 PM UTC

Transforming Immuno-Oncology: Akoya Biosciences Innovative Leap with the PhenoCode Discovery IO60 Amidst Market ChallengesIn the realm of immuno-oncology, few developments are as pivotal as the technologies that emerge to advance our understanding of tumor microenvironments and the immune responses they provoke. Akoya Biosciences Inc. a prominent entity in this field, has ...
Product Service News

Unlocking the Future of Cancer Immunotherapy Akoyas Innovative Role in the MANIFEST Consortium

Published Mon, Oct 7 2024 12:00 PM UTC

In a remarkable advancement for cancer research and immunotherapy, Akoya Biosciences Inc. has emerged as a pivotal player in the UK-based MANIFEST Consortium, a groundbreaking initiative aimed at revolutionizing how cancer is detected and treated. This consortium, spearheaded by the esteemed Francis Crick Institute and The Royal Marsden NHS Foundation Trust, comprises a coal...
Partnership

Akoya Biosciences and NeraCare Strike Exclusive Partnership to Boost Personalized Therapy for Early-Stage Melanoma Patients

Published Thu, May 9 2024 12:00 PM UTC

Akoya Biosciences Inc., an industry leader known for the market-leading PhenoImager HT platform and its robust clinical development capabilities, have recently entered into an exclusive agreement with NeraCare. This collaborative synergy is set to revolutionize personalized therapy selection for patients with early-stage melanoma.The partnership brings together Akoya s super...
Management Announcement

Akoya Biosciences Ramps Up Operations in Marlborough, Massachusetts to Revolutionize Spatial Biology Research

Published Mon, May 6 2024 12:00 PM UTC

Akoya Biosciences Expands Operations and Manufacturing Center of Excellence in Marlborough to Meet Growing Demand
Marlborough, Massachusetts - Akoya Biosciences, Inc., a leading Spatial Biology Company, announced the opening of its Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts. This expansion comes as a response to the surging demand f...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.81
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.25
Working Capital Ratio 0.61
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.97 $
Revenues (TTM) 1.6 $
Cash Flow (TTM) 0.15 $
Cash 0.55 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 238,348
Net Income per Employee (TTM) -142,742
Receivable Turnover Ratio (TTM) 5.79
Inventory Turnover Ratio (TTM) 1.23
Asset Turnover Ratio (TTM) 0.62

Profitability Ratios Current
Gross Margin (MRQ) 62.2 %
Operating Margin (MRQ) -84.51 %
Net Margin (MRQ) -98.62 %
Net Cash Flow Margin (MRQ) 54.06 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Akoya Biosciences Inc's Segments
Single reportable segment    104.84 % of total Revenue
North America    63.88 % of total Revenue
APAC    16.29 % of total Revenue
EMEA    24.67 % of total Revenue

  Akoya Biosciences Inc Outlook

On March 4 2024 the Akoya Biosciences Inc provided following guidance

Akoya Biosciences Inc. has reported record revenue in the fourth quarter of 2023, with $26.5 million in revenue for the quarter and a to...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.